Xilio Therapeutics, Inc. (XLO)
0.7227
0.00 (0.00%)
USD |
NASDAQ |
Dec 11, 16:00
0.7245
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics EPS Diluted (Quarterly): -0.113 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| BioXcel Therapeutics, Inc. | -2.177 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.29M |
| Revenue (Quarterly) | 19.07M |
| Total Expenses (Quarterly) | 35.35M |
| Enterprise Value | -58.80M |
| Gross Profit Margin (Quarterly) | 98.22% |
| Profit Margin (Quarterly) | -85.42% |
| Earnings Yield | -90.95% |
| Normalized Earnings Yield | -80.56 |